TNFSF13B and systemic lupus erythematosus: Recent studies provided further evidence of targeting of BAFF/BLys and APRIL in the management of lupus (86–88); and another study reported the effect of hCDR1 on IL-7 and apoptosis (89) and showed the rate of apoptosis is reduced with hCDR1 treatment in lupus mice.